Brief: Medadvisor Announces Withdrawal Of FY26 Revenue Guidance
29/08/2025 02:35
Aug 29 (Reuters) - Medadvisor Ltd MDR.AX: WITHDRAWAL OF FY26 REVENUE GUIDANCE DUE TO PREVAILING SHORT-TERM MARKET UNCERTAINTY UNDERTAKING COMPREHENSIVE EVALUATION OF BEST PATH FORWARD TO MAXIMISE SHAREHOLDER VALUE FOR US BUSINESS Further company coverage: MDR.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adheris Health
See all newsBrief: Adheris Health Posts Q3 Operating Revenue Of A$5.4M
Brief: Adheris Health Posts HY Profit From Ordinary Activities After Tax Attributable A$7.3 Million
Brief: Adheris Health Expects 30% Total Operating Cost Savings Over Two Years
Brief: Adheris Health Posts Q2 Operating Revenue A$13.7 Million
Brief: Adheris Health Says A$6.1M Holdback Consideration Received